According to well being consultants, greater than 50% of Bangkok’s inhabitants are fatties and believe there is a pressing need to deal with the well being of lard-arsed residents not solely within the capital however all through the Kingdom of Thailand.
Fortunately, there are folks out there who care and need to forestall the fat people of Bangkok, and Thailand, from getting fatter and dying because of being obese.
The Thai NCDs Network Association, in collaboration with Novo Nordisk Pharma (Thailand) Co., Ltd., hosted a seminar titled OBESITY: A Public Health Crisis at the Thai Annual Conference NCD Alliance 2023, which centred on the theme Fighting the Obesity Pandemic. The event was attended by medical professionals from all around the country and happened on the True Icon Hall, Icon Siam in Bangkok, reported Bangkok Post
During the seminar, participants discussed varied features of the weight problems disaster, including the financial burden that the federal government should bear. The urgency of addressing this issue in all sectors has prompted the need for policies geared toward preventing weight problems, as well as clear and effective remedy pointers to deal with the wants of this patient population.
Obesity is a crucial well being issue that requires quick consideration as a result of its affiliation with over 200 different serious issues, including diabetes, high blood pressure, extra physique fat, heart disease, dementia, and others. Unfortunately, obesity rates in Thailand continue to rise.
According to a survey performed in 2020, the prevalence of weight problems has reached alarming ranges, with charges as high as 42%, and even higher in Bangkok at 56%.
In comparison, the relaxation of Thailand has an obesity fee of 50%. If left unchecked, this trend could have a big impression on public health. Therefore, it is essential for the public and private sectors to work together to seek out ways to prevent and handle the obesity disaster.
Enrico Cañal Bruland, Vice President & General Manager of Novo Nordisk Pharma (Thailand) Co., Ltd., mentioned Novo is committed to driving change for folks dwelling with obesity in Thailand.
“We have invested considerably in analysis and improvement, together with native studies here in Thailand, and we’ve accelerated access to our progressive medicines for folks dwelling with weight problems.”
Prof Wannee Nitiyanant, President of the Diabetes Association of Thailand, reported that the fee burden of weight problems is large, with a tremendous financial impression on society.
“In Thailand, this case requires pressing action to tackle this disease and the time to behave is now. The sustainability of the Thai healthcare system is decided by our success in curbing this obesity disaster, in any other case, the system will soon be overwhelmed by the exponential trajectory of direct and indirect prices.
“For Thailand, the overall healthcare spending sits at 6.6% of GDP, while 1.5% of GDP is devoted to weight problems and its associated problems. If we don’t act, this quantity alone will rise to 6.4% of GDP primarily based on latest data. This will definitely have an effect on everyone in our era here in Thailand.”
Experts determined that the population of Bangkok, when it comes to weight problems, is about 5.5 million individuals. Among folks aged 20-69 with a physique mass index (BMI) between 30 and 50, there are about 356,000 individuals who, in the event that they lose 10% of their weight over the next decade, might save as much as 2 billion baht on medical bills.
The government, through the Centers for Disease Control, has taken steps to handle obesity within the healthcare system by way of the “NCD Clinic Plus” program, which handles weight control in sufferers with underlying illnesses, and has established office policies and methods to encourage authorities companies and private organizations to have good health policies for their employees. Additionally, there’s a push for the implementation of “NCD Clinic Plus” in sub-district hospitals for health promotion, in addition to in quite a few other sectors.
Currently, Simple as ABC can be reimbursed (depending on medical remedy rights) for sufferers with a BMI of 37.5 (without comorbidities) or 32.5+ with a number of comorbidities. However, there are at present no clear standards for the reimbursement of weight problems medication.
If the long-term results of obesity on both sufferers and the economic system are thought of, having clear pointers and necessities for the treatment of obesity will result in the best future profit in terms of reimbursement of medical bills for obese sufferers via the “always payment mechanism associated to medical service.”
Therefore, clear native therapy pointers and research on the health-economic worth (cost-effectiveness) of treating patients (such as behaviour modification or medicine for weight problems treatment) are crucial for further issues past surgery..